![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/19/2915994/0/en/BioSenic-S-A-Transparency-notification-received-from-Mr-Fran%C3%A7ois-Rieger.html
https://www.globenewswire.com/news-release/2024/07/18/2915008/0/en/BioSenic-releases-new-in-depth-analysis-of-its-positive-phase-2-clinical-data-for-optimal-administration-scheme-for-its-next-late-stage-trial-of-arsenic-trioxide-ATO-targeting-cGvH.html
https://www.globenewswire.com/news-release/2024/07/12/2912512/0/en/BioSenic-S-A-Transparency-notification-received-from-V%C3%A9ronique-Pomi.html
https://www.globenewswire.com/news-release/2024/07/05/2908872/0/en/Medsenic-subsidiary-of-BioSenic-SA-extends-key-patent-to-the-United-States.html
https://www.globenewswire.com/news-release/2024/07/02/2907129/0/en/Medsenic-BioSenic-s-subsidiary-signed-a-new-set-of-licensing-and-commercialization-agreements-with-Phebra-PTY-Ltd.html
https://www.globenewswire.com/news-release/2024/06/28/2905645/0/en/BioSenic-S-A-Information-on-the-total-number-of-voting-rights-and-shares.html
https://www.globenewswire.com/news-release/2024/06/21/2902446/0/en/BioSenic-signs-a-new-subscription-agreement-for-a-maximum-of-EUR-2-1M-in-convertible-bonds.html
https://www.globenewswire.com/news-release/2024/06/14/2898763/0/en/The-Enterprise-Court-of-Nivelles-approves-the-BioSenic-restructuring-plan.html
https://www.globenewswire.com/news-release/2024/06/12/2897273/0/en/BioSenic-to-host-Annual-General-Meeting-on-July-12-2024.html
https://www.globenewswire.com/news-release/2024/06/06/2895011/0/en/BioSenic-announces-2023-full-year-results.html